세계의 가정 주입 치료 시장 조사 보고서 : 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2025-2033년)

Global Home Infusion Therapy Market size is anticipated to grow from USD 19.56 Billion in 2024 to USD 36.48 Billion by 2033, showcasing a robust Compound Annual Growth Rate (CAGR) of 7.17% during the forecast period of 2026 to 2033.

The home infusion therapy market is experiencing a surge in demand as healthcare systems increasingly recognize the benefits of delivering care in the comfort of patients' homes. This shift is driven by the growing prevalence of chronic diseases, the aging population, and the rising costs associated with hospital stays. Home infusion therapy offers a viable alternative, allowing patients to receive necessary treatments, such as antibiotics, chemotherapy, and pain management, while minimizing hospital visits. The convenience and comfort of home-based care are appealing to both patients and healthcare providers, positioning this market for substantial growth.

Technological advancements are significantly enhancing the home infusion therapy landscape. The development of portable infusion devices and smart technology solutions is improving the safety and efficiency of home-based treatments. These innovations enable healthcare professionals to monitor patients remotely, ensuring adherence to treatment protocols and timely interventions when necessary. Additionally, the integration of telehealth services is facilitating better communication between patients and healthcare providers, further enhancing the quality of care. As technology continues to evolve, the home infusion therapy market is expected to expand, driven by increased patient engagement and improved treatment outcomes.

Moreover, the regulatory environment is becoming more supportive of home infusion therapy, with policies aimed at promoting patient-centered care and reducing healthcare costs. As reimbursement models evolve to favor home-based treatments, healthcare providers are more likely to invest in home infusion services. The growing awareness of the benefits of home care, coupled with advancements in technology and supportive regulations, positions the home infusion therapy market for robust growth in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

SEGMENTATION COVERED IN THE REPORT

By Product Type

• Infusion Pumps
• Intravenous Set
• IV Cannulas
• Needleless Connectors

By Application

• Chemotherapy
• Diabetes
• Hydration Therapy
• Pain Management
• Post-transplant Therapies
• Parenteral Nutrition Therapy
• Others
• COMPANIES PROFILED
• Baxter International Inc
• B. Braun Melsungen AG
• Fresenius Kabi AG
• Smiths Medical
• CareCentrix Inc.
• Coram CVS/specialty infusion services
• Option Care Health Inc.
• CVS Health
• UnitedHealth Group (Optum)
• McKesson Corporation
• PharMerica Corporation
• BioScrip Inc.
• MedicoRx Specialty Pharmacy
• InfuSystem
• Diplomat Pharmacy Inc.
• The above list can be customized.

TABLE OF CONTENTS

1. PREFACE

• 1.1. Report Description
  • 1.1.1 Objective
  • 1.1.2 Target Audience
  • 1.1.3 Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1 Market Research Process
  • 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3. HOME INFUSION THERAPY INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porters Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Product Type
  • 3.7.2 Market Attractiveness Analysis By Application
  • 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1 List of Raw Materials
  • 4.2.2 Raw Material Manufactures List
  • 4.2.3 Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1 Direct Marketing
  • 4.4.2 Indirect Marketing
  • 4.4.3 Marketing Channel Development Trend

5. GLOBAL HOME INFUSION THERAPY MARKET ANALYSIS BY PRODUCT TYPE

• 5.1. Overview By Product Type
• 5.2. Historical and Forecast Data Analysis By Product Type
• 5.3. Infusion Pumps Historic and Forecast Sales By Regions
• 5.4. Intravenous Set Historic and Forecast Sales By Regions
• 5.5. IV Cannulas Historic and Forecast Sales By Regions
• 5.6. Needleless Connectors Historic and Forecast Sales By Regions

6. GLOBAL HOME INFUSION THERAPY MARKET ANALYSIS BY APPLICATION

• 6.1. Overview By Application
• 6.2. Historical and Forecast Data Analysis By Application
• 6.3. Chemotherapy Historic and Forecast Sales By Regions
• 6.4. Diabetes Historic and Forecast Sales By Regions
• 6.5. Hydration Therapy Historic and Forecast Sales By Regions
• 6.6. Pain Management Historic and Forecast Sales By Regions
• 6.7. Post-transplant Therapies Historic and Forecast Sales By Regions
• 6.8. Parenteral Nutrition Therapy Historic and Forecast Sales By Regions
• 6.9. Others Historic and Forecast Sales By Regions

7. GLOBAL HOME INFUSION THERAPY MARKET ANALYSIS BY GEOGRAPHY

• 7.1. Regional Outlook
• 7.2. Introduction
• 7.3. North America Sales Analysis
  • 7.3.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.3.2 North America By Segment Sales Analysis
  • 7.3.3 North America By Country Sales Analysis
  • 7.3.4 United States Sales Analysis
  • 7.3.5 Canada Sales Analysis
  • 7.3.6 Mexico Sales Analysis
• 7.4. Europe Sales Analysis
  • 7.4.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.4.2 Europe By Segment Sales Analysis
  • 7.4.3 Europe By Country Sales Analysis
  • 7.4.4 United Kingdom Sales Analysis
  • 7.4.5 France Sales Analysis
  • 7.4.6 Germany Sales Analysis
  • 7.4.7 Italy Sales Analysis
  • 7.4.8 Russia Sales Analysis
  • 7.4.9 Rest Of Europe Sales Analysis
• 7.5. Asia Pacific Sales Analysis
  • 7.5.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.5.2 Asia Pacific By Segment Sales Analysis
  • 7.5.3 Asia Pacific By Country Sales Analysis
  • 7.5.4 China Sales Analysis
  • 7.5.5 India Sales Analysis
  • 7.5.6 Japan Sales Analysis
  • 7.5.7 South Korea Sales Analysis
  • 7.5.8 Australia Sales Analysis
  • 7.5.9 South East Asia Sales Analysis
  • 7.5.10 Rest Of Asia Pacific Sales Analysis
• 7.6. Latin America Sales Analysis
  • 7.6.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.6.2 Latin America By Segment Sales Analysis
  • 7.6.3 Latin America By Country Sales Analysis
  • 7.6.4 Brazil Sales Analysis
  • 7.6.5 Argentina Sales Analysis
  • 7.6.6 Peru Sales Analysis
  • 7.6.7 Chile Sales Analysis
  • 7.6.8 Rest of Latin America Sales Analysis
• 7.7. Middle East & Africa Sales Analysis
  • 7.7.1 Overview, Historic and Forecast Data Sales Analysis
  • 7.7.2 Middle East & Africa By Segment Sales Analysis
  • 7.7.3 Middle East & Africa By Country Sales Analysis
  • 7.7.4 Saudi Arabia Sales Analysis
  • 7.7.5 UAE Sales Analysis
  • 7.7.6 Israel Sales Analysis
  • 7.7.7 South Africa Sales Analysis
  • 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE HOME INFUSION THERAPY COMPANIES

• 8.1. Home Infusion Therapy Market Competition
• 8.2. Partnership/Collaboration/Agreement
• 8.3. Merger And Acquisitions
• 8.4. New Product Launch
• 8.5. Other Developments

9. COMPANY PROFILES OF HOME INFUSION THERAPY INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Market Concentration Rate
• 9.3. Baxter International Inc
  • 9.3.1 Company Overview
  • 9.3.2 Company Revenue
  • 9.3.3 Products
  • 9.3.4 Recent Developments
• 9.4. B. Braun Melsungen AG
  • 9.4.1 Company Overview
  • 9.4.2 Company Revenue
  • 9.4.3 Products
  • 9.4.4 Recent Developments
• 9.5. Fresenius Kabi AG
  • 9.5.1 Company Overview
  • 9.5.2 Company Revenue
  • 9.5.3 Products
  • 9.5.4 Recent Developments
• 9.6. Smiths Medical
  • 9.6.1 Company Overview
  • 9.6.2 Company Revenue
  • 9.6.3 Products
  • 9.6.4 Recent Developments
• 9.7. CareCentrix Inc.
  • 9.7.1 Company Overview
  • 9.7.2 Company Revenue
  • 9.7.3 Products
  • 9.7.4 Recent Developments
• 9.8. Coram CVS/Specialty Infusion Services
  • 9.8.1 Company Overview
  • 9.8.2 Company Revenue
  • 9.8.3 Products
  • 9.8.4 Recent Developments
• 9.9. Option Care Health Inc.
  • 9.9.1 Company Overview
  • 9.9.2 Company Revenue
  • 9.9.3 Products
  • 9.9.4 Recent Developments
• 9.10. CVS Health
  • 9.10.1 Company Overview
  • 9.10.2 Company Revenue
  • 9.10.3 Products
  • 9.10.4 Recent Developments
• 9.11. UnitedHealth Group (Optum)
  • 9.11.1 Company Overview
  • 9.11.2 Company Revenue
  • 9.11.3 Products
  • 9.11.4 Recent Developments
• 9.12. McKesson Corporation
  • 9.12.1 Company Overview
  • 9.12.2 Company Revenue
  • 9.12.3 Products
  • 9.12.4 Recent Developments
• 9.13. PharMerica Corporation
  • 9.13.1 Company Overview
  • 9.13.2 Company Revenue
  • 9.13.3 Products
  • 9.13.4 Recent Developments
• 9.14. BioScrip Inc.
  • 9.14.1 Company Overview
  • 9.14.2 Company Revenue
  • 9.14.3 Products
  • 9.14.4 Recent Developments
• 9.15. MedicoRx Specialty Pharmacy
  • 9.15.1 Company Overview
  • 9.15.2 Company Revenue
  • 9.15.3 Products
  • 9.15.4 Recent Developments
• 9.16. InfuSystem
  • 9.16.1 Company Overview
  • 9.16.2 Company Revenue
  • 9.16.3 Products
  • 9.16.4 Recent Developments
• 9.17. Diplomat Pharmacy Inc
  • 9.17.1 Company Overview
  • 9.17.2 Company Revenue
  • 9.17.3 Products
  • 9.17.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies